<DOC>
	<DOCNO>NCT00543127</DOCNO>
	<brief_summary>Postmenopausal woman hormone receptor positive negative Her2 tumour . Estimation 5-year disease-free survival control arm 80 % . The experimental arm expect increase 5-year disease-free survival 4 % ( 84 % ) . With alpha error 0.05 80 % power , 1445 patient per arm need . Assuming 10 % post-randomization drop-out , 3180 patient total need . Before randomization , patient stratify accord center , positive node ( 0 vs. 1-3 vs. ≥4 ) , previous chemotherapy ( yes v ) hormonal receptor status .</brief_summary>
	<brief_title>Fulvestrant ( Faslodex ) + Anastrozol ( Arimidex ) v Anastrozol</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Fulvestrant</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<criteria>1 . Written sign informed consent . 2 . Breast cancer histologically confirm . 3 . Stages I , II , IIIA invasive breast cancer . Patients must comply one follow characteristic : N+ , T &gt; 2 cm . 4 . Mastectomy lumpectomy free margin + radiotherapy , axilar node dissection centinel node dissection . 5 . Positive hormonal receptor ( ER+ and/or PgR+ ) determine central laboratory . 6 . Negative HER2 ( define IHQ 0 1+ negative FISH IHQ 2+ 3+ ) . 7 . Postmenopausal woman ( woman comply one follow criterion : age ≥ 60 year , age ≥ 45 year amenorrhea , amenorrhea ≥ 12 month undamaged uterus , bilateral ovariectomy , FSH estradiol level postmenopausal range ( use local range ) . 8 . ECOG = 0 , 1 2 . 9 . Age &gt; 18 year . 1 . Metastatic disease invasive bilateral breast cancer . 2 . Negative ER PgR breast cancer . 3 . Treatment approve experimental drug within 4 week randomization . 4 . Current previous malignant process within last 5 year ( different breast cancer basocelular carcinoma escamocelular skin cervix carcinoma situ ) . 5 . Pregnant lactating woman . 6 . Concurrent hormone replacement therapy hormonal agent ( raloxifen , tamoxifen , etc . )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>